April 2024
181 articles-
Apr 30 · 00:19Biotechnology Daily
Amphista demonstrates protein degraders’ ‘rapid’ efficacy against tumor, CNS targets in animals
-
Apr 30 · 00:18Biotechnology Daily
Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss
-
Apr 30 · 00:16Biotechnology Daily
Samsung allotting ‘significant investment’ to bring noninvasive glucose sensor to wearables: Bloomberg
-
Apr 30 · 00:15Biotechnology Daily
Cognito deepens analysis of neuromod device for Alzheimer’s with launch of biomarker substudy
-
Apr 30 · 00:13Bio Business News
J&J sees deal ‘opportunities’ in neuroscience and immunology post-Ambrx buy
-
Apr 30 · 00:05Bio Business News
J&J highlights Abiomed’s first year in 2023 medtech earnings
-
Apr 30 · 00:04Bio Business News
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
-
Apr 30 · 00:03Bio Business News
NAYA buys Florida Biotechnologies for $20M to get hold of rare genetic disease drug
-
Apr 29 · 22:33Market Watch
Cyclacel Pharmaceuticals Shares Up 72% After Hours on Withdrawal of Offering
-
Apr 29 · 00:36Biotechnology Daily
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
-
Apr 29 · 00:35Biotechnology Daily
Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
-
Apr 29 · 00:34Biotechnology Daily
FDA sets new record for novel device green lights in CDRH annual report
-
Apr 29 · 00:33Biotechnology Daily
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
-
Apr 29 · 00:32Bio Business News
Two more pharmas practice their Accent, invest in $75M series C round
-
Apr 29 · 00:31Bio Business News
Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs
-
Apr 29 · 00:30Bio Business News
Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
-
Apr 29 · 00:29Bio Business News
Accelus accelerates expansion of spine implant tech with $20M infusion
-
Apr 25 · 23:17Biotechnology Daily
Approved IBS drug Bentyl may help overcome chemo-resistant prostate cancer
-
Apr 25 · 23:16Biotechnology Daily
Ionis’ HAE drug bests placebo in phase 3, setting up run to FDA approval
-
Apr 25 · 23:15Biotechnology Daily
FDA clears vibrating belt to boost brittle bones in women facing osteoporosis
-
Apr 25 · 23:14Biotechnology Daily
Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech
-
Apr 25 · 23:13Bio Business News
Sagimet stock doubles as phase 2b MASH trial hits primary goals, despite dropout queries
-
Apr 25 · 23:11Bio Business News
Arrivent anticipates $135M IPO as biotechs continue to eye public market
-
Apr 25 · 23:11Bio Business News
Itch treater Cara cuts 50% of team to extend cash runway into 2026